Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol and Cognitive Processing Therapy for Comorbid PTSD and AUD
NCT05692271Phase 2Completed
- Sponsor
- Center for Addiction and Mental Health
- Start
- Jul 2023
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol in post-traumatic stress disorder (PTSD), alcohol use disorder (AUD), sponsored by Center for Addiction and Mental Health. Started Jul 2023; status: completed.
02
Drugs
propranolol
03
Conditions
post-traumatic stress disorder (PTSD)alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT05692271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05692271.